Advances in the etiology and treatment of non-obese nonalcoholic fatty liver disease / 临床肝胆病杂志
Journal of Clinical Hepatology
; (12): 452-457, 2021.
Article
in Zh
| WPRIM
| ID: wpr-873421
Responsible library:
WPRO
ABSTRACT
With the prevalence of nonalcoholic fatty liver disease (NAFLD) in the non-obese population, more and more studies have explored the significance of NAFLD in such population. Compared with the patients with obese NAFLD, the patients with non-obese NAFLD lack the phenotype of obesity, but they still have metabolic disorders and higher risk of metabolic and cardiovascular diseases. At present, there are no effective drugs for the treatment of non-obese NAFLD, and the existing treatment methods have their own advantages and limitations in clinical practice. This article reviews the advances in the etiology and treatment of non-obese NAFLD, in order to provide a reference for guiding the clinical treatment of non-obese NAFLD.
Full text:
1
Index:
WPRIM
Type of study:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
Language:
Zh
Journal:
Journal of Clinical Hepatology
Year:
2021
Type:
Article